OLIGONUCLEOTIDE THERAPEUTICS SOCIETY
Data sourced from IRS 990 public filings
OLIGONUCLEOTIDE THERAPEUTICS SOCIETY OTS is an educational organization that brings together scientists from around the world to share research and foster collaborations in an effort to further the development of oligonucleotide therapeutic drug development.
Annual Revenue
$1,653,140
Known Funders
0
Grants Received
0
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $1,653,140 | $1,324,007 | $2,063,953 |
| 2023 | $1,561,718 | $1,644,646 | $1,734,820 |
| 2022 | $1,230,167 | $1,077,810 | $1,817,748 |
| 2021 | $788,991 | $388,431 | $1,697,866 |
| 2020 | $601,451 | $313,631 | $1,260,770 |
| 2019 | $844,284 | $830,066 | $977,950 |
| 2018 | $822,106 | $667,627 | $963,733 |
| 2017 | $629,580 | $505,203 | $809,254 |
Top Funders
No funder data available yet for this nonprofit.
Key Personnel
From 2024 IRS 990 filing
JOHN ROSSI
HONORARY MEMBER
MANO MANOHARAN
HONORARY MEMBER
MIKE GAIT
HONORARY MEMBER
FRITZ ECKSTEIN
HONORARY MEMBER
EVA-MARIE MANZ
TRAINEE REP
KRYSTAL JOHNSON
TRAINEE REP
JILLIAN BELGRAD
TRAINEE REP
JATHAVAN ASOHAN
TRAINEE REP
TIMOTHY YU
Director
MARIE WIKSTROM LINDHOLM
Director
Showing 10 of 25 key personnel.
Frequently Asked Questions
Other Nonprofits in California
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.